Our Heritage

Cenduit, LLC is a privately owned joint venture of the industry powerhouses; Quintiles and Fisher Clinical Services, a division of Thermo Fisher Scientific.

Cenduit has successfully deployed IRT solutions in over 600 clinical studies. Cenduit’s IRT solution is currently being used in Phase I through Phase IV clinical trials by over 32,000 sites in nearly 100 countries, to enroll more than 230,000 subjects for over 30 indications. There are currently 50+ languages utilized in the Cenduit IRT platform, supporting all languages in the ISO country list.

Cenduit is dedicated to Quality, Partnership, Efficiency, and Exemplary Customer Service. Cenduit has over 200 domain specialists consisting of project management, technical, validation, programming, and quality control/assurance global staff located in Research Triangle Park, North Carolina USA, Allentown, Pennsylvania USA, Horsham, London UK, Basel, Switzerland, and Bangalore, India.

Cenduit LLC is a joint venture between Quintiles and Thermo Fisher Scientific, providing IWRS / IVRS Solutions. Cenduit’s powerful global enterprise unleashes an unprecedented level of clinical trial support by performing as the central conduit of data between the clinical development expertise of Quintiles and the clinical supply chain expertise of Fisher Clinical Services.